339 related articles for article (PubMed ID: 10424731)
1. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas.
Florl AR; Löwer R; Schmitz-Dräger BJ; Schulz WA
Br J Cancer; 1999 Jul; 80(9):1312-21. PubMed ID: 10424731
[TBL] [Abstract][Full Text] [Related]
2. Selective changes of retroelement expression in human prostate cancer.
Goering W; Ribarska T; Schulz WA
Carcinogenesis; 2011 Oct; 32(10):1484-92. PubMed ID: 21828060
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma.
Jürgens B; Schmitz-Dräger BJ; Schulz WA
Cancer Res; 1996 Dec; 56(24):5698-703. PubMed ID: 8971178
[TBL] [Abstract][Full Text] [Related]
4. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.
Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
J Urol; 2005 Jan; 173(1):243-6. PubMed ID: 15592089
[TBL] [Abstract][Full Text] [Related]
5. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
[TBL] [Abstract][Full Text] [Related]
6. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2).
Lavie L; Kitova M; Maldener E; Meese E; Mayer J
J Virol; 2005 Jan; 79(2):876-83. PubMed ID: 15613316
[TBL] [Abstract][Full Text] [Related]
7. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas.
Menendez L; Benigno BB; McDonald JF
Mol Cancer; 2004 Apr; 3():12. PubMed ID: 15109395
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma.
Cho M; Uemura H; Kim SC; Kawada Y; Yoshida K; Hirao Y; Konishi N; Saga S; Yoshikawa K
Br J Cancer; 2001 Aug; 85(4):563-7. PubMed ID: 11506497
[TBL] [Abstract][Full Text] [Related]
10. HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma.
Kreimer U; Schulz WA; Koch A; Niegisch G; Goering W
Front Oncol; 2013; 3():255. PubMed ID: 24133654
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
[TBL] [Abstract][Full Text] [Related]
12. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines.
Büscher K; Trefzer U; Hofmann M; Sterry W; Kurth R; Denner J
Cancer Res; 2005 May; 65(10):4172-80. PubMed ID: 15899808
[TBL] [Abstract][Full Text] [Related]
13. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA
Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166
[TBL] [Abstract][Full Text] [Related]
14. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.
Chalitchagorn K; Shuangshoti S; Hourpai N; Kongruttanachok N; Tangkijvanich P; Thong-ngam D; Voravud N; Sriuranpong V; Mutirangura A
Oncogene; 2004 Nov; 23(54):8841-6. PubMed ID: 15480421
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
18. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
[TBL] [Abstract][Full Text] [Related]
19. Widely variable endogenous retroviral methylation levels in human placenta.
Reiss D; Zhang Y; Mager DL
Nucleic Acids Res; 2007; 35(14):4743-54. PubMed ID: 17617638
[TBL] [Abstract][Full Text] [Related]
20. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
